Stocks and Investing Stocks and Investing
Fri, May 6, 2022
Thu, May 5, 2022

Steven Seedhouse Maintained (APLS) at Strong Buy with Decreased Target to $102 on, May 5th, 2022


Published on 2024-10-27 20:53:09 - WOPRAI, Steven Seedhouse
  Print publication without navigation


Steven Seedhouse of Raymond James, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $114 to $102 on, May 5th, 2022.

Steven has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Steven's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Steven


  • Elemer Piros of "Roth Capital" Downgraded from Hold to Strong Sell and Held Target at $40 on, Thursday, April 14th, 2022
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Monday, April 4th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $86 on, Monday, March 7th, 2022
  • Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
Contributing Sources